FDFT1 Up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with FDFT1 Up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with FDFT1 Up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with FDFT1 Up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with FDFT1 Up.

Results found

Linked to

 

Label

Description

 

Gene

ENSG00000087263 - 2-oxoglutarate and iron dependent oxygenase domain containing 1

Gene

ENSG00000142694 - eva-1 homolog B

Gene

ENSG00000101441 - cystatin S

Gene

ENSG00000006712 - PAF1 component of Paf1/RNA polymerase II complex

Gene

ENSG00000147119 - carbohydrate sulfotransferase 7

Gene

ENSG00000101213 - protein tyrosine kinase 6

Gene

ENSG00000102218 - RP2 activator of ARL3 GTPase

Gene

ENSG00000232629 - major histocompatibility complex, class II, DQ beta 2

  • Gene

    ENSG00000087263 - 2-oxoglutarate and iron dependent oxygenase domain containing 1


  • Gene

    ENSG00000142694 - eva-1 homolog B


  • Gene

    ENSG00000101441 - cystatin S


  • Gene

    ENSG00000006712 - PAF1 component of Paf1/RNA polymerase II complex


  • Gene

    ENSG00000147119 - carbohydrate sulfotransferase 7


  • Gene

    ENSG00000101213 - protein tyrosine kinase 6


  • Gene

    ENSG00000102218 - RP2 activator of ARL3 GTPase


  • Gene

    ENSG00000232629 - major histocompatibility complex, class II, DQ beta 2

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.